Evaluating sglt2 inhibitor application in heart failure patients across the spectrum in a large multi-hospital healthcare network

11 May 2026 (16:00 - 17:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Ms Ximena Zalazar

Piedmont Heart Institute, Atlanta (United States of America)

5 More presentations in this session

Presentation thumbnail

Evolution of heart failure management in korea: a serial comparison of physician awareness and practice patterns (2019 vs. 2025)

Associate Professor S. Lee (Seoul, KR)

Abstract Slides

Presentation thumbnail

Variation in initial pharmacological therapy for heart failure with reduced ejection fraction: an international case-based survey

Mr H. Amin (Enschede, NL)

Abstract Slides

Presentation thumbnail

Safety of sodium-glucose cotransporter-2 inhibitor in low body mass index patients who have heart failure with reduced ejection fraction

Doctor J. Lee (Hwaseong, KR)

Abstract Slides

Presentation thumbnail

Implementation of guideline-directed pharmacotherapy in hospitalized and outpatient heart failure care: a web-based survey

Professor M. Tokmakova (Plovdiv, BG)

Abstract Slides

Presentation thumbnail

Patient and prescriber knowledge of SGLT2i sick day rules: a single centre cohort study

Doctor B. Woolfenden (Dublin 9, IE)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy (8)

The Event

Event poster

Heart Failure 2026

11 May 2026 16:00 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Webinar

MRAs in heart failure: what's old is new again

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources